{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:20:01Z","timestamp":1792513201396,"version":"4.5.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Insulin is considered to be a key antigenic target of T cells in Type 1 Diabetes (T1D) and autoimmune diabetes in the NOD mouse with particular focus on the B-chain amino acid sequence B:9-23 as the primary epitope. Our lab previously discovered that hybrid insulin peptides (HIPs), comprised of insulin C-peptide fragments fused to other \u03b2-cell granule peptides, are ligands for several pathogenic CD4 T cell clones derived from NOD mice and for autoreactive CD4 T cells from T1D patients. A subset of CD4 T cell clones from our panel react to insulin and B:9-23 but only at high concentrations of antigen. We hypothesized that HIPs might also be formed from insulin B-chain sequences covalently bound to other endogenously cleaved \u00df-cell proteins. We report here on the identification of a B-chain HIP, termed the 6.3HIP, containing a fragment of B:9-23 joined to an endogenously processed peptide of ProSAAS, as a strong neo-epitope for the insulin-reactive CD4 T cell clone BDC-6.3. Using an I-A\n                    <jats:sup>g7<\/jats:sup>\n                    tetramer loaded with the 6.3HIP, we demonstrate that T cells reactive to this B-chain HIP can be readily detected in NOD mouse islet infiltrates. This work suggests that some portion of autoreactive T cells stimulated by insulin B:9-23 may be responding to B-chain HIPs as peptide ligands.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2022.926650","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T03:13:49Z","timestamp":1660101229000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes"],"prefix":"10.3389","volume":"13","author":[{"given":"Janet M.","family":"Wenzlau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"DiLisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Barbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mylinh","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita C.","family":"Hohenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Delong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocky L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Haskins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.2000.0444","article-title":"It's insulin","volume":"15","author":"Wegmann","year":"2000","journal-title":"J Autoimmun"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.040556697","article-title":"Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes","volume":"97","author":"Yu","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0300","article-title":"Patterns of beta-cell autoantibody appearance and genetic associations during the first years of life","volume":"62","author":"Ilonen","year":"2013","journal-title":"Diabetes"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.6362005","article-title":"Insulin antibodies in insulin-dependent diabetics before insulin treatment","volume":"222","author":"Palmer","year":"1983","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/BF00408359","article-title":"Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies","volume":"34","author":"B\u00f6hmer","year":"1991","journal-title":"Diabetologia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.11.2451","article-title":"International workshop on lessons from animal models for human type 1 diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice","volume":"50","author":"Bonifacio","year":"2001","journal-title":"Diabetes"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1288.002","article-title":"The second murine autoantibody workshop: remarkable interlaboratory concordance for radiobinding assays to identify insulin autoantibodies in nonobese diabetic mice","volume":"1005","author":"Yu","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4258-7","article-title":"Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility","volume":"60","author":"Pollanen","year":"2017","journal-title":"Diabetologia"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240820","article-title":"Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice","volume":"24","author":"Wegmann","year":"1994","journal-title":"Eur J Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2337\/diab.45.10.1299","article-title":"Diabetogenic T-cell clones","volume":"45","author":"Haskins","year":"1996","journal-title":"Diabetes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1113954108","article-title":"Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse","volume":"108","author":"Crawford","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/db18-0200","article-title":"CD4 T cells reactive to hybrid insulin peptides are indicators of disease activity in the NOD mouse","volume":"67","author":"Baker","year":"2018","journal-title":"Diabetes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180300","article-title":"Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity","volume":"215","author":"Ito","year":"2018","journal-title":"J Exp Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(05)87004-X","article-title":"Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse","volume":"87","author":"Haskins","year":"2005","journal-title":"Adv Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4049\/jimmunol.1501190","article-title":"Cutting edge: Nonobese diabetic mice deficient in chromogranin a are protected from autoimmune diabetes","volume":"196","author":"Baker","year":"2016","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1901079","article-title":"Characterization of proinsulin T cell epitopes restricted by type 1 diabetes-associated HLA class II molecules","volume":"204","author":"Ihantola","year":"2020","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jim.2005.01.001","article-title":"An efficient method for cloning human autoantigen-specific T cells","volume":"298","author":"Mannering","year":"2005","journal-title":"J Immunol Methods"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.03907.x","article-title":"The a-chain of insulin is a hot-spot for CD4+ T cell epitopes in human type 1 diabetes","volume":"156","author":"Mannering","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1809208115","article-title":"Proinsulin c-peptide is an autoantigen in people with type 1 diabetes","volume":"115","author":"So","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jaut.2008.02.001","article-title":"CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope","volume":"31","author":"Yang","year":"2008","journal-title":"J Autoimmun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603682103","article-title":"DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype","volume":"103","author":"Durinovic-Bello","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI8525","article-title":"A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin","volume":"107","author":"Alleva","year":"2001","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0858","article-title":"Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes","volume":"64","author":"Pathiraja","year":"2015","journal-title":"Diabetes"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2337\/dbi19-0022","article-title":"T-Cell epitopes and neo-epitopes in type 1 diabetes: A comprehensive update and reappraisal","volume":"69","author":"James","year":"2020","journal-title":"Diabetes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4203","article-title":"Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes","volume":"22","author":"Babon","year":"2016","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.622647","article-title":"Proinsulin-reactive CD4 T cells in the islets of type 1 diabetes organ donors","volume":"12","author":"Landry","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1214","article-title":"Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes","volume":"63","author":"van Lummel","year":"2014","journal-title":"Diabetes"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad2791","article-title":"Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion","volume":"351","author":"Delong","year":"2016","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4289","article-title":"Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes","volume":"23","author":"Kracht","year":"2017","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111502","article-title":"Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletion","volume":"208","author":"Mohan","year":"2011","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2010.03362.x","article-title":"T-Cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes","volume":"131","author":"Babad","year":"2010","journal-title":"Immunology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250430","article-title":"Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice","volume":"25","author":"Daniel","year":"1995","journal-title":"Eur J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00365","article-title":"Determining antigen specificity of human islet infiltrating T cells in type 1 diabetes","volume":"10","author":"Nakayama","year":"2019","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nature03523","article-title":"Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice","volume":"435","author":"Nakayama","year":"2005","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.072037299","article-title":"Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to h-2K(d) that stimulates CD8 T cells in insulin-dependent diabetes mellitus","volume":"99","author":"Wong","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0800","article-title":"Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes","volume":"58","author":"Wong","year":"2009","journal-title":"Diabetes"},{"key":"B37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1084\/jem.183.1.67","article-title":"CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells","volume":"183","author":"Wong","year":"1996","journal-title":"J Exp Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0128","article-title":"Hybrid insulin peptides are autoantigens in type 1 diabetes","volume":"68","author":"Baker","year":"2019","journal-title":"Diabetes"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.668680","article-title":"Characterization of human CD4 T cells specific for a c-Peptide\/C-Peptide hybrid insulin peptide","volume":"12","author":"Wiles","year":"2021","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.10.007","article-title":"An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse","volume":"78","author":"Wiles","year":"2017","journal-title":"J Autoimmun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.8b00875","article-title":"Identification of hybrid insulin peptides (HIPs) in mouse and human islets by mass spectrometry","volume":"18","author":"Wiles","year":"2019","journal-title":"J Proteome Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0620","article-title":"Hybrid insulin peptides are recognized by human T cells in the context of DRB1*04:01","volume":"69","author":"Arribas-Layton","year":"2020","journal-title":"Diabetes"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.2019129118","article-title":"T-Cell responses to hybrid insulin peptides prior to type 1 diabetes development","volume":"118","author":"Mitchell","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.20.8000","article-title":"Pancreatic islet-specific T-cell clones from nonobese diabetic mice","volume":"86","author":"Haskins","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1502967112","article-title":"Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects","volume":"112","author":"Nakayama","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301480","article-title":"Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice","volume":"191","author":"Baker","year":"2013","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0288","article-title":"Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells","volume":"60","author":"Delong","year":"2011","journal-title":"Diabetes"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200600584","article-title":"Predicting peptides bound to I-Ag7 class II histocompatibility molecules using a novel expectation-maximization alignment algorithm","volume":"7","author":"Chang","year":"2007","journal-title":"Proteomics"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.8.2435","article-title":"The first external domain of the nonobese diabetic mouse class II I-a beta chain is unique","volume":"84","author":"Acha-Orbea","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.aaw6329","article-title":"Position beta57 of I-A(g7) controls early anti-insulin responses in NOD mice, linking an MHC susceptibility allele to type 1 diabetes onset","volume":"4","author":"Gioia","year":"2019","journal-title":"Sci Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.47.10.1570","article-title":"Prevention of diabetes in NOD mice by a mutated I-ab transgene","volume":"47","author":"Singer","year":"1998","journal-title":"Diabetes"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/9.10.1523","article-title":"The role of I-Ag7 beta chain in peptide binding and antigen recognition by T cells","volume":"9","author":"Kanagawa","year":"1997","journal-title":"Int Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.6.3214","article-title":"The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder","volume":"165","author":"Stratmann","year":"2000","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0623-7","article-title":"The MHC-II peptidome of pancreatic islets identifies key features of autoimmune peptides","volume":"21","author":"Wan","year":"2020","journal-title":"Nat Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1129","article-title":"On the pathogenicity of autoantigen-specific T-cell receptors","volume":"57","author":"Burton","year":"2008","journal-title":"Diabetes"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2013.09.006","article-title":"Blockade of islet amyloid polypeptide fibrillation and cytotoxicity by the secretory chaperones 7B2 and proSAAS","volume":"587","author":"Peinado","year":"2013","journal-title":"FEBS Lett"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-02-00639.2000","article-title":"Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing","volume":"20","author":"Fricker","year":"2000","journal-title":"J Neurosci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M600443-MCP200","article-title":"Proteomics analysis of insulin secretory granules","volume":"6","author":"Brunner","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.10.6051","article-title":"The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form","volume":"178","author":"Levisetti","year":"2007","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/imr.12430","article-title":"The role of islet antigen presenting cells and the presentation of insulin in the initiation of autoimmune diabetes in the NOD mouse","volume":"272","author":"Unanue","year":"2016","journal-title":"Immunol Rev"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.092260499","article-title":"Distinct recognition by two subsets of T cells of an MHC class II-peptide complex","volume":"99","author":"Pu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e88242","DOI":"10.1172\/jci.insight.88242","article-title":"Tissue distribution and clonal diversity of the T and b cell repertoire in type 1 diabetes","volume":"1","author":"Seay","year":"2016","journal-title":"JCI Insight"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.6.2518","article-title":"T Cell receptor restriction of diabetogenic autoimmune NOD T cells","volume":"94","author":"Simone","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.2000.0369","article-title":"Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse","volume":"14","author":"Abiru","year":"2000","journal-title":"J Autoimmun"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0057","article-title":"Paradigm shift or shifting paradigm for type 1 diabetes","volume":"61","author":"Nakayama","year":"2012","journal-title":"Diabetes"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41502","article-title":"The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity","volume":"120","author":"Yoshida","year":"2010","journal-title":"J Clin Invest"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.926650\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T03:13:53Z","timestamp":1660101233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.926650\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2022.926650"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.926650","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"article-number":"926650"}}